LQDA Q4 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-35.6% YoY

Gross Profit

$2M53.6% margin

Operating Income

-$36M-1237.8% margin

Net Income

-$38M-1315.4% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-34.4%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$26M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$230M

Total Liabilities

$153M

Stockholders' Equity

$77M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$5M	-35.6%
Gross Profit	$2M	$4M	-55.8%
Operating Income	-$36M	-$26M	-36.6%
Net Income	-$38M	-$27M	-39.8%